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Introduction
With the advent of microorganism identification via non-culture
techniques, it is now well recognized that the upper respiratory
tract as well as the the lower respiratory tract of healthy
individuals is normally colonized by a large number of bacteria.
The recognition of the lung microbiome indicates that several
aspects of our traditional model of pneumonia pathogenesis
were incorrect. In this commentary, I will speculate regarding
the possible mechanisms of pneumonia pathogenesis. I will also
contemplate the possibility that in some patients, an episode
of acute pneumonia may evolve into a chronic subclinical
pneumonia.
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Figure 1. The sterile alveolus (1.A) and the traditional model of pneumonia
pathogenesis with bacteria arriving and multiplying in the alveoli (1.B) and
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the development of a local inflammatory response (1.C).

Our traditional approach to the pathogenesis of pneumonia
was based on the wrong assumption that the alveoli were sterile
(Figure 1.A). In this outdated model, the first step in the
development of pneumonia was the arrival of bacteria to the
alveoli (Figure 1.B). Once bacteria arrived to the alveoli, the
next step was dependent of the interaction between invading
bacteria and alveolar macrophages, with two possible outcomes.
Alveolar macrophages may kill the bacteria, restoring the
alveolar space to the normal sterile condition, or the bacteria
may overcome alveolar macrophages and multiply in the
alveolar space. In response to this uncontrolled bacterial
multiplication, alveolar macrophages will produce cytokines,
and the local and systemic inflammatory response characteristic
of pneumonia will ensue (Figure 1.C). In this traditional model
there was a single pathway for the development of pneumonia.

The lung microbiome
At the alveolar level, the lung microbiome is constituted primarily of anaerobic organisms, with predominance of the phylum
Bacteroidetes (1). Some microorganisms are living freely in the
alveolar space, in a planktonic form, but half of the bacterial
communities are attached to alveolar cells (2). It is likely that
most of these organisms are living in cell-associated biofilm
communities (Figure 2.A).
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New models of pneumonia pathogenesis
The pathogenesis of pneumonia may still involve the arrival of
new bacteria into the alveolar space. Once these new bacteria arrive to the alveoli, the interaction will be among the new bacteria, the alveolar macrophages, and the alveolar microbiota. The
newly arrived bacteria will need to overcome the alveolar macrophages as well as the normal alveolar flora to be able to multiply and cause pneumonia (Figure 2.B). If the lung microbiome
is an integral part of the lung innate immunity, an abnormal
alveolar microbiota, or dysbiosis, may be an important risk factor for the development of pneumonia. Prior antibiotic use may
predispose to pneumonia by altering the alveolar microbiome.
As part of the pathogenesis of pneumonia, the need for the arrival
of bacteria to the alveoli is not longer necessary, since bacteria,
as well as viruses and fungi, are part of the normal alveolar
microbiota. We can speculate that pneumonia may develop by
the uncontrolled multiplication of some of the bacteria already
present in the alveoli. In this model of pathogenesis, depicted in
Figure 2.C, the etiologic agent of pneumonia will be bacteria
that typically constitute the alveoli normal flora. This scenario
may explain why in some patients with pneumonia an etiologic
agent is not identified, since these bacteria can not be isolated
using regular culture techniques.
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A final model of pathogenesis may include a combination of
uncontrolled multiplication of new bacteria arriving to the
alveoli associated to uncontrolled multiplication of some of
the species present in the alveolar microbiota (Figure 2.D). In
this type of pathogenesis, the etiology of pneumonia will be
polymicrobial, with a combination of invading bacteria plus
bacteria normally present in the alveoli.
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Figure 2. The lung microbiome (2.A) and three possible models
for pneumonia pathogenesis (2.B, 2.C, and 2.D).

A new respiratory infection: Chronic
subclinical pneumonia
Persistent subclinical inflammation has been documented
in some patients after clinical resolution of an episode of
community-acquired pneumonia (3). These patients are at
increased risk for cardiovascular events, rehospitalization, and
mortality. The reason for this persistent lung inflammation is
not clear. It can be speculated that current antibiotic therapy
for pneumonia is able to kill invading microorganisms, but an
abnormal alveolar microbiota may persist even after the patient
is clinically cured. The persistent multiplication of some species
belonging to the alveolar microbiota will set the stage for a
subclinical respiratory infection associated to low level chronic
lung inflammation, an entity that can be defined as chronic
subclinical pneumonia. This unregulated lung inflammation
may persist until the normal alveolar bacteria composition
is restored. Therapeutic interventions aimed to restore
homeostasis of the lung microbiome may be necessary to curtail
chronic lung inflammation after an episode of pneumonia.

Conclusion
From all the ideas expressed in this opinion piece, we can be
certain that our traditional model of pneumonia pathogenesis
is incorrect. All other concepts regarding the role of the lung
microbiome in the pathogenesis of acute pneumonia or the
development of chronic subclinical pneumonia are only
hypothesis that will need to be tested with further research.
The lung microbiome has forced all investigators in the field of
pneumonia to go back to the drawing board.
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